Pharmacokinetic Characteristics of GLH1SM Extended Release Tablets in Healthy Volunteers
Condition: Healthy Interventions: Combination Product: Janumet XR tablet 100/1000 mg; Combination Product: GLH1SM tablet 100/1000 mg Sponsor: GL Pharm Tech Corporation Enrolling by invitation
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials